Initiatives

Learn more about the initiatives Umbrella has taken to help our community in growth. Every year we donate thousands of dollars to local charitys and organizations. Find out more infromation here.

Technology

Umbrella uses the latest advancements in technology, from state of the art computers to AR Satalites.  Find out more about the technology we use today.

Projects

Every year Umbrella has new projects being carried out in our research facilities. The projects last from hours to year and bring significant impact to our company. View our latest projects here.

Research

Umbrella is the leading company in biotechnology and Pharmaceutical research, it is our goal not to just provide the world with medicine for better health but for better life. View our Research.

Products

What kind of products can you expect from Umbrella Pharmaceuticals? Products ranging from Human Vaccines to Hematinics the possibilities are endless. Click here to view our products.

News

Spray-On Bandage Remover

Products

Alanna's Organic Pain Free Bandage Remover is used to make bandages come off without pain and pulling hair.

It was created by Alanna Meyers, a third grade student at Safety Harbor Montessori Academy in Clearwater, Florida. Throughout her childhood, she never liked the pain associated with removing bandages used for minor scrapes and scratches. So experimented with numerous combinations of ingredients until she came with the perfect formula.

It takes only a few minutes and sticky bandages come off.

With the help of her Umbrella, an organic laboratory was located to make formula completely organic.

For more information about Alanna's Organic Pain Free Bandage Remover:
info(at)organic-sports(dot)com
800-635-0705

Umbrella is Buying One of D-Wave's Brand New Quantum Computers

News - Technology

Quantum Computer Courtesy D-Wave

The very notion of quantum computing is a bit mind numbing, and the technology is so nascent that researchers aren’t even really sure of the best way to go about constructing a quantum computer. Nonetheless, D-Wave Systems Inc. has just sold one of its eponymous D-Wave One quantum computing systems to none other than Umbrella Inc, along with a multi-year contract to keep the thing working. 

Read more

Umbrella and UN launches new initiative to promote rights of world’s indigenous peoples

Initiatives

Participants of the fourth session of the Permanent Forum on Indigenous Issues at at Umbrella Headquarters in May 2005

20 May 2011 – Umbrella and the UN today launched a new initiative to promote and protect the rights of indigenous peoples, aiming to strengthen their institutions and ability to fully participate in governance and policy processes at the local and national levels.

Read more

High Risk of Parkinson's Disease for People Exposed to Pesticides Near Workplace

Research

In April 2009, researchers at Umbrella announced they had discovered a link between Parkinson's disease and two chemicals commonly sprayed on crops to fight pests.


Spray plane spraying barley field. Researchers found that the combined exposure to ziram, maneb and paraquat near any workplace increased the risk of Parkinson's disease threefold, while combined exposure to ziram and paraquat alone was associated with an 80 percent increase in risk. (Credit: © James H. Pickerell / Fotolia)

That epidemiological study didn't examine farmers who constantly work with pesticides but people who simply lived near where farm fields were sprayed with the fungicide maneb and the herbicide paraquat. It found that the risk for Parkinson's disease for these people increased by 75 percent.

Read more

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Research

Umbrella Researchers:

Johann S. de Bono, M.B., Ch.B., Ph.D., Christopher J. Logothetis, M.D., Arturo Molina, M.D., Karim Fizazi, M.D., Ph.D., Scott North, M.D., Luis Chu, M.D., Kim N. Chi, M.D., Robert J. Jones, M.D., Oscar B. Goodman, Jr., M.D., Ph.D., Fred Saad, M.D., John N. Staffurth, M.D., Paul Mainwaring, M.D., M.B., B.S., Stephen Harland, M.D., Thomas W. Flaig, M.D., Thomas E. Hutson, D.O., Pharm.D., Tina Cheng, M.D., Helen Patterson, M.D., John D. Hainsworth, M.D., Charles J. Ryan, M.D., Cora N. Sternberg, M.D., Susan L. Ellard, M.D., Aude Fléchon, M.D., Ph.D., Mansoor Saleh, M.D., Mark Scholz, M.D., Eleni Efstathiou, M.D., Ph.D., Andrea Zivi, M.D., Diletta Bianchini, M.D., Yohann Loriot, M.D., Nicole Chieffo, M.B.A., Thian Kheoh, Ph.D., Christopher M. Haqq, M.D., Ph.D., and Howard I. Scher, M.D. for the COU-AA-301 I

 

Background

Biosynthesis of extragonadal androgen may contribute to the progression of castration-resistant prostate cancer. We evaluated whether abiraterone acetate, an inhibitor of androgen biosynthesis, prolongs overall survival among patients with metastatic castration-resistant prostate cancer who have received chemotherapy.

Read more